stockrow
Monday 9 November 2026
Export PDSB’s income statement to Excel — free account
PDS Biotechnology Corporation
PDSB- EPS
- +14.3%
- Free cash flow
- +69.3%
- Total debt
- −66.6%
Quarter to June 2026, against a year earlier
1.23
0.06
+5.13%
Follow PDSB
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(221.81%) | (244.16%) | (254.09%) | (543.97%) | |
| (80.05%) | (90.95%) | (93.05%) | (136.65%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(237.49%) | (182.60%) | (259.50%) | 653.10% | |
Free Cash Flow per Share |
(0.69) | (0.60) | (0.42) | (0.30) | |
Free Cash Flow |
(32.28) | (27.75) | (23.09) | (16.78) | |
| Other line items | |||||
Cash ROIC |
(67.86%) | (52.51%) | (63.83%) | (264.35%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(6.06) | (5.91) | (5.34) | (4.18) | |
Operating CF/Net income |
0.93 | 0.80 | 0.69 | 0.50 | |
Depreciation/Fixed assets |
11.45 | 13.43 | 15.61 | 5.33 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.69) | (0.60) | (0.42) | (0.30) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates